News Story: Full Text
Sponsored By
Gleolan for brain tumors
Please Click On The Above Banner For More Details
Braintumor Website

 

GT Medical Technologies Announces FDA Clearance of Expanded Indication for GammaTile Therapy (Correction)

Al's Comment:

 Correction - I sent this out in the last news blast but my comments were incorrect.  I said it adds 10 months to the progression free survival time, which is the number for all types of brain tumors, not just GBM.  For GBM it is 4 months, which is still very good.  For metastatic tumors and meningiomas it is a lot more!


Posted on: 01/30/2020

GT Medical Technologies Announces FDA Clearance of Expanded Indication for GammaTile Therapy

 


Click HERE to return to brain tumor news headlines


Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2020 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740